- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 5/062 - Dipeptides the side chain of the first amino acid being acyclic, e.g. Gly, Ala
Patent holdings for IPC class C07K 5/062
Total number of patents in this class: 793
10-year publication summary
|
81
|
88
|
90
|
90
|
84
|
62
|
80
|
48
|
54
|
22
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Biohaven Therapeutics Ltd. | 88 |
13 |
| Bristol-myers Squibb Company | 5080 |
12 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
12 |
| MedImmune Limited | 627 |
12 |
| Nissan Chemical Industries, Ltd. | 1822 |
11 |
| Albireo AB | 157 |
10 |
| Medivir AB | 142 |
10 |
| Allergan, Inc. | 2600 |
9 |
| Cornell University | 3036 |
9 |
| On Target Laboratories, LLC | 37 |
9 |
| Case Western Reserve University | 1727 |
8 |
| Helsinn Healthcare SA | 255 |
8 |
| Hoffmann-La Roche Inc. | 3060 |
7 |
| ImmunoGen, Inc. | 405 |
7 |
| Ono Pharmaceutical Co., Ltd. | 454 |
7 |
| The University of Tokyo | 3903 |
7 |
| Arvinas Operations, Inc. | 165 |
7 |
| The Johns Hopkins University | 5377 |
6 |
| Ambrx, Inc. | 191 |
6 |
| NeoStrata Company, Inc. | 11 |
6 |
| Other owners | 617 |